Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
19:00:41 EDT Fri 25 Sep 2026
Enter Symbol
or Name
USA
CA



Q:TLTFF - THERALASE TECHNOLOGIES INC - https://theralase.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TLTFF - Qnot subscribed0.1239-0.0026-2.1118.513280.1274  0.1274  0.121130.3061  0.101914:57:23Sep 1815 min RT 2¢

Recent Trades - Last 10 of 28
Time ETExPriceChangeVolume
14:57:23Q0.1239-0.00264,000
14:57:23Q0.1239-0.0026500
14:57:23Q0.1239-0.00266,500
14:57:23Q0.1239-0.002610,000
14:57:23Q0.1239-0.002614,000
14:57:23Q0.1239-0.002614,500
14:57:23Q0.1239-0.00269,500
14:57:23Q0.1239-0.00267,500
14:57:23Q0.1239-0.00262,500
14:57:23Q0.1239-0.00261,000

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-09-18 07:01U:TLTFFNews ReleaseCorrecting and Replacing: Theralase(R) Releases Q2 2026 Financial Statements
2026-09-15 07:02U:TLTFFNews ReleaseTheralase(R) Commences GLP Toxicology Analysis of Rutherrin(R)
2026-08-28 16:37U:TLTFFNews ReleaseTheralase(R) Releases Q2 2026 Financial Statements
2026-08-07 17:26U:TLTFFNews ReleaseTheralase(R) Grants Stock Options
2026-08-04 07:02U:TLTFFNews ReleaseTheralase(R) Engages Global One Media to Expand Global Investor Awareness
2026-06-30 16:32U:TLTFFNews ReleaseTheralase(R) Receives Receipt for C$100 Million Base Shelf Prospectus
2026-06-03 07:02U:TLTFFNews ReleaseTheralase(R) Lists Warrants on the TSXV
2026-05-29 17:05U:TLTFFNews ReleaseTheralase(R) Releases Q1 2026 Financial Statements
2026-05-04 17:23U:TLTFFNews ReleaseTheralase(R) Releases 2025 Annual Financial Statements and Provides Clinical Study Update
2026-04-13 07:01U:TLTFFNews ReleaseTheralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study
2026-04-10 07:01U:TLTFFNews ReleaseTheralase(R) Closes $CAN 2.66 Million Financing
2026-03-17 07:02U:TLTFFNews ReleaseTheralase(R) Discovers Further Mechanism on How Ruvidar(R) Inactivates Herpes Simplex Virus
2026-03-10 07:02U:TLTFFNews ReleaseTheralase(R) Closes $1.1 M Non-Brokered Private Placement
2026-03-09 07:02U:TLTFFNews ReleaseTheralase(R) Demonstrates That X-Ray-Activated Rutherrin(R) Is Significantly More Effective than Radiation Alone in the Destruction of Muscle Invasive Bladder Cancer
2026-03-02 07:02U:TLTFFNews ReleaseLight-Activated Ruvidar and Interferon Demonstrate Enhanced Efficacy
2026-02-20 07:01U:TLTFFNews ReleaseCorrecting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress
2026-02-17 07:02U:TLTFFNews ReleaseTheralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress
2026-02-10 07:02U:TLTFFNews ReleaseTheralase(R) Bladder Cancer Clinical Data to be Presented at the 2026 American Urological Association Annual Meeting
2026-02-04 07:02U:TLTFFNews ReleaseTheralase(R) Provides Update on Bladder Cancer Clinical Study
2026-02-02 07:03U:TLTFFNews ReleaseTheralase(R) Completes Enrollment in Bladder Cancer Clinical Study